About the Company
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
3300
Exchange
NYSE
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $HAE News
Is Haemonetics Corporation's (NYSE:HAE) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Haemonetics' (NYSE:HAE) stock is up by a considerable 12% over the past month. Given the company's impressive performance, we decided to study its financial indicators more closely as a company's ...
Haemonetics Poised for Growth with Strong Q4 Projections and Strategic Acquisitions
Begin your TipRanks Premium journey today. Haemonetics (HAE) Company Description: Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates ...
Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval
Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...
Haemonetics Corp.
No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...
Haemonetics Corporation
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate.
Haemonetics Corporation Completes Acquisition of Attune Medical
BOSTON, April 1, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...
Haemonetics Gets 510 (K) Clearance For TEG 6s Hemostasis - HN Cartridge
(RTTNews) - Haemonetics Corp. (HAE) on Thursday announced that it has received 510(k) clearance from the FDA for the new TEG 6s Hemostasis analyzer system Global Hemostasis-HN assay cartridge.
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes ...
Haemonetics Corporation Completes Acquisition of Attune Medical
Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized because they are based upon Haemonetics' current ...
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...
Loading the latest forecasts...